CLOs on the Move

York Dental Cerama Laboratory Inc

www.yorkdentallab.com

 
York Dental Cerama Laboratory Inc is a New Haven, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

FusionHealth

Fusion Health head office is based in beautiful Byron Bay, product development, regulatory affairs and techincal support teams in Sydney and the National Sales department is based in Melbourne. All of our herbal medicines are manufactured in Sydney to natural pharmaceutical standards in accordance with the latest guidelines from the Australian Therapeutic Goods Administration (TGA).

Artisan Dental Laboratories

Artisan Dental Laboratories is a Portland, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Jounce Therapeutics

Jounce Therapeutics, Inc. is a clinical-stage immunotherapy company dedicated to transforming the treatment of cancer by developing therapies that enable the immune system to attack tumors and provide long lasting benefits to patients through a biomarker-driven approach. Through the use of its Translational Science Platform, Jounce first focuses on specific cell types within the human tumor microenvironment to prioritize targets, and then identifies related biomarkers designed to match the right immunotherapy to the right patient. Jounce is developing two clinical-stage programs as well as advancing and building out its broad and wholly-owned discovery pipeline of immuno-oncology targets, including those expressed on T-regulatory cells, macrophages and stromal cells. Jounce`s lead product candidate, vopratelimab, is a monoclonal antibody that binds to and activates ICOS and is currently being assessed in a Phase 2 clinical trial. JTX-4014 is a PD-1 inhibitor intended for use in combination with future pipeline products, and Jounce has completed enrollment in the JTX-4014 Phase 1 clinical trial. In addition, Jounce has exclusively licensed worldwide rights to JTX-8064, a LILRB2 receptor antagonist, to Celgene. For more information, please visit www.jouncetx.com. We have many career opportunities at Jounce and are looking for exceptional individuals who share our passion and perseverance for developing highly durable cancer immunotherapies that can dramatically impact and improve patients` lives.

Brogan Heart Center

Brogan Heart Center is a Lubbock, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

D-PATH

D-PATH is a Memphis, TN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.